Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
691.30M | 681.67M | 673.70M | 567.44M | 509.48M | Gross Profit |
323.64M | 434.00M | 438.78M | 369.64M | 325.16M | EBIT |
108.67M | 126.26M | 167.92M | 117.83M | 57.36M | EBITDA |
156.07M | 166.39M | 174.02M | 172.36M | 48.37M | Net Income Common Stockholders |
96.89M | 116.10M | 120.35M | 111.46M | 288.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
217.84M | 206.39M | 253.16M | 225.59M | 130.95M | Total Assets |
1.05B | 1.04B | 992.77M | 856.88M | 766.46M | Total Debt |
18.54M | 13.33M | 16.26M | 20.01M | 24.71M | Net Debt |
-103.75M | -66.87M | -124.95M | -84.08M | -94.47M | Total Liabilities |
148.56M | 146.88M | 177.60M | 153.55M | 219.59M | Stockholders Equity |
903.40M | 897.24M | 815.75M | 703.91M | 547.44M |
Cash Flow | Free Cash Flow | |||
49.30M | 6.27M | 82.58M | 111.81M | 46.06M | Operating Cash Flow |
124.08M | 90.87M | 122.24M | 135.53M | 105.46M | Investing Cash Flow |
-31.50M | -76.90M | -28.01M | -134.43M | -12.28M | Financing Cash Flow |
-52.70M | -60.74M | -55.30M | -17.84M | -37.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £107.66M | 20.19 | 8.61% | 1.96% | -11.80% | -32.11% | |
71 Outperform | £612.27M | 38.39 | 5.31% | 1.90% | -5.56% | -27.87% | |
70 Outperform | £1.95B | 19.96 | 11.07% | 2.84% | 4.71% | 0.43% | |
65 Neutral | £555.48M | 53.33 | 12.29% | 1.17% | -1.84% | 9.56% | |
62 Neutral | £2.05B | 8.88 | 17.33% | 3.89% | -11.09% | 65.87% | |
60 Neutral | $11.59B | 10.39 | -7.23% | 2.94% | 7.46% | -10.76% | |
58 Neutral | £133.06M | 46.53 | 2.87% | 2.56% | -8.41% | -31.29% |
Renishaw plc reported steady progress in its third quarter, with revenue reaching £180.7 million, marking a 5% increase year-on-year. The company experienced growth in machine tool probes and position encoders, while also announcing the closure of its loss-making drug delivery segment in the Neurological business to enhance profitability. Despite challenges such as tariffs and increased labor costs, Renishaw maintains a strong balance sheet and continues to focus on productivity and strategic investments to support future growth.
Spark’s Take on GB:RSW Stock
According to Spark, TipRanks’ AI Analyst, GB:RSW is a Neutral.
Renishaw demonstrates strong financial stability and operational efficiency, complemented by a reasonable valuation and positive corporate events. However, weak technical momentum tempers the overall score, indicating potential risks in market performance despite the company’s underlying strengths.
To see Spark’s full report on GB:RSW stock, click here.
Renishaw plc announced a transaction involving its Chief Executive, William Ernest Lee, who acquired 1,788 ordinary shares at a price of £22.37 each on the London Stock Exchange. This acquisition reflects a significant investment by the company’s leadership, potentially indicating confidence in Renishaw’s future performance and market position.
Spark’s Take on GB:RSW Stock
According to Spark, TipRanks’ AI Analyst, GB:RSW is a Neutral.
Renishaw demonstrates a strong financial position with efficient operations and a robust balance sheet. However, technical analysis indicates weak market momentum, which tempers the overall score. Valuation metrics suggest a fair price, while recent corporate events highlight positive growth prospects, though they do not significantly alter the current technical trends.
To see Spark’s full report on GB:RSW stock, click here.